Atezolizumab

Tax included
Atezolizumab (MPDL3280A) is a selective humanized monoclonal IgG1 antibody against programmed death ligand 1 (PD-L1), used for cancer research.
MedChemExpress 
HY-P9904

Data sheet

Size
Multiple sizes
Reactivity
PD-1/PD-L1; Apoptosis; Autophagy
Application
Cancer-programmed cell death
CAS
1380723-44-3